Xbox Series X

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

ProbablyMonsters announces Crimson Moon action RPG, targeting 2026 release across PC and consoles

Can Crimson Moon turn ProbablyMonsters into a serious challenger in the premium action RPG market?

ProbablyMonsters has revealed Crimson Moon, a new action RPG launching in 2026. Find out why this title matters for premium gaming strategy.

byVenkatesh

February 13, 2026

Mecha BREAK’s July 2025 launch: What is Amazing Seasun Games bringing to the global shooter market?

Amazing Seasun Games launches Mecha BREAK globally on July 1, 2025 across Steam and Xbox, targeting competitive shooter fans with anime-powered mech combat.

byPallavi Madhiraju

June 7, 2025

The Latest

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Can Crimson Moon turn ProbablyMonsters into a serious challenger in the premium action RPG market?

Mecha BREAK’s July 2025 launch: What is Amazing Seasun Games bringing to the global shooter market?

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up

Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution

NATCO Pharma (NSE: NATCOPHARM) wins CDSCO approval for semaglutide as FDA compliance risks recede at its API unit

Zydus Lifesciences (NSE: Zyduslife) secures FDA approval for ammonium lactate cream as U.S. generics execution deepens